Resonance Health Files New Provisional Patent
Filed with ASX · · 2 pages · English
Story so far
Earlier from Resonance Health
- Market Update
- Controlled Placement Facility
- Licencee & Royalty Agreement with 3DR Laboratories
- Resonance Health Partners with Siemens Healthineers
- New AI Tool for Automated Assessment of Liver Fat
Later from Resonance Health
- Execution of Licence Agreement
- New Pulmonary Embolism AI Solution Developed
- HepaFat-AI gains US FDA clearance
- HepaFat-AI Incorporated into Blackford Analysis
- HepaFat-AI Receives TGA Approval
Follow Resonance Health into a list and get an email when it puts out news.
Follow Resonance Health